Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study

References

• Allison DB, Fontaine KR, Heo M, Mentore JL, Cappelleri JC, Chandler LP, et al. The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry 1999; 60: 215–220
   PubMed Web of Science ®Google Scholar
• Allison DB, Casey DE. Antipsychotic-induced weight gain: a review of the literature. J Clin Psychiatry 2001; 62(Suppl 7)22–31
   PubMed Web of Science ®Google Scholar
• Baptista T, Kin NMKNY, Beaulieu S, de Baptista EA. Obesity and related metabolic abnormalities during antipsychotic administration: mechanisms, management and research perspectives. Pharmacopsychiatry 2002; 35: 205–219
   PubMed Web of Science ®Google Scholar
• Basson BR, Kinon BJ, Taylor CC, Szymanski KA, Gilmore JA, Tollefson GD. Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone. J Clin Psychiatry 2001; 62: 231–238
   PubMed Web of Science ®Google Scholar
• Elsmlie JL, Silverstone JT, Mann JI, Williams SM, Romans SE. Prevalence of overweight and obesity in bipolar patients. J Clin Psychiatry 2000; 61: 179–184
   PubMedGoogle Scholar
• Evans S, Newton R, Higgins S. Nutritional intervention to prevent weight gain in patients commenced on olanzapine: a randomized controlled trial. Aust NZ J Psychiatry 2005; 39: 479–486
   PubMed Web of Science ®Google Scholar
• Gothelf D, Falk B, Singer P, Kairi M, Phillip M, Zigel L, et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 2002; 159: 1055–1057
   PubMed Web of Science ®Google Scholar
• Guy, W. 1976. Clinical global impression, In. W Guy. ECDEU Assessment Manual for Psychopharmacology (revised). Publication ADM 76-338. Bethesda, MD: US Department of Health, Education, and Welfare. 217–221.
   Google Scholar
• Haddad PM, Sharma SG. Adverse effects of atypical antipsychotics. Differential risk and clinical implications. CNS Drugs 2007; 21: 911–936
   PubMed Web of Science ®Google Scholar
• Jones B, Basson BR, Walker DJ, Crawford AMK, Kinon BJ. Weight change and atypical antipsychotic treatment in patients with schizophrenia. J Clin Psychiatry 2001; 62(Suppl 2)41–44
   PubMed Web of Science ®Google Scholar
• Kinon BJ, Basson BR, Gilmore JA, Tollefson GD. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia. J Clin Psychiatry 2001; 62: 92–100
   PubMed Web of Science ®Google Scholar
• Kinon BJ, Kaiser CJ, Ahmed S, Rotelli MD, Kollack-Walker S. Association between early and rapid weight gain and change in weight over one year of olanzapine therapy in patients with schizophrenia and related disorders. J Clin Psychopharmacol 2005; 25: 255–258
   PubMed Web of Science ®Google Scholar
• Kwon JS, Choi JS, Bahk WM, Kim CY, Kim CH, Shin YC, et al. Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: a 12-week randomized controlled clinical trial. J Clin Psychiatry 2006; 67: 547–553
   PubMed Web of Science ®Google Scholar
• Lipkovich I, Citrome L, Perlis R, Deberdt W, Houston JP, Ahl J, et al. Early predictors of substantial weight gain in bipolar patients treated with olanzapine. J Clin Psychopharmacol 2006; 26: 316–320
   PubMed Web of Science ®Google Scholar
• Lipkovich I, Jacobson JG, Hardy TA, Poole Hoffmann V. Early evaluation of patient risk for substantial weight gain during olanzapine treatment for schizophrenia, schizophreniform, or schizoaffective disorder. BMC Psychiatry 2008; 8: 78
   PubMedGoogle Scholar
• Marder, SR, Noordsy, DL, Glynn, SM, O'Keefe, C, Almeida, MA. 2006. Two year outcomes on risperidone and olanzapine in stable patients with schizophrenia. Neuropsychopharmacology, 31(Suppl 1)s250, (Abstract 131).
   Google Scholar
• Mauri M, Simoncini M, Castrogiovanni S, Iovieno N, Cecconi D, Dell'Agnello G, et al. A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacopsychiatry 2008; 41: 17–23
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Trakas K, Lin D, Balshaw R, Hwang P, Robinson K, Eggleston A. Risk of weight gain associated with antipsychotic treatment: results from the Canadian National Outcomes Measurement Study in Schizophrenia. Can J Psychiatry 2003; 48: 689–694
   PubMed Web of Science ®Google Scholar
• Poyurovsky M, Fuchs C, Pashinian A, Levi A, Faragian S, Maayan R, et al. Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind, placebo-controlled study. Psychopharmacology 2007; 192: 441–448
   PubMed Web of Science ®Google Scholar
• Rege S. Antipsychotic induced weight gain in schizophrenia: mechanisms and management. Aust NZ J Psychiatry 2008; 42: 369–381
   PubMed Web of Science ®Google Scholar
• Saddichha S, Ameen S, Akhtar S. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol. J Clin Psychopharmacol 2008; 28: 27–31
   PubMed Web of Science ®Google Scholar
• Smith, E, Rothschild, AJ, Heo, M, Peasley-Miklus, C, Caswell, M, Papademetriou, E, , et al. Weight gain during olanzapine treatment for psychotic depression: effects of dose and age. Int Clin Psychopharmacol, 23:130–137.
   PubMedGoogle Scholar
• Strassnig M, Miewald J, Keshavan M, Ganguli R. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis. Schizophr Res 2007; 93: 90–98
   PubMed Web of Science ®Google Scholar
• Taylor DM, McAskill R. Atypical antipsychotics and weight gain – a systematic review. Acta Psychiatr Scand 2000; 101: 416–432
   PubMed Web of Science ®Google Scholar
• Treuer T, Karagianis J, Poole-Hoffman V. Can increased food intake improve psychosis? A brief review and hypothesis. Curr Mol Pharmacol 2008; 1: 270–272
   PubMedGoogle Scholar
• Ujike H, Nomura A, Morita Y, Morio A, Okahisa Y, Kotaka T, et al. Multiple genetic factors in olanzapine-induced weight gain in schizophrenia patients: a cohort study. J Clin Psychiatry 2008; 69: 1416–1422
   PubMed Web of Science ®Google Scholar
• WHO Expert Consultation . 2004. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet, 363:157–163.
   PubMed Web of Science ®Google Scholar
• Zipursky RB, Gu H, Green AI, Perkins DO, Tohen MF, McEvoy JP, et al. Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry 2005; 187: 537–543
   PubMed Web of Science ®Google Scholar